发明名称 BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS
摘要 The present invention provides novel pyrimidine amines of formula I which are potent inhibitors of spleen tyrosine kinase, or are prodrugs thereof, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis and cancer.
申请公布号 US2014249130(A1) 申请公布日期 2014.09.04
申请号 US201214116199 申请日期 2012.05.04
申请人 Deschenes Denis;Altman Michael D.;Ellis John Michael;Fischer Christian;Haidle Andrew M.;Kattar Solomon D.;Northrup Alan B.;Schell Adam J.;Smith Graham F.;Taoka Brandon M.;Bienstock Corey;Di Francesco Maria Emilia;Donofrio Anthony;Peterson Scott;Spencer Kerrie B.;Jewell James Patrick;Ali Amjad;Bennett David Jonathan;Dang Qun;Wai John 发明人 Deschenes Denis;Altman Michael D.;Ellis John Michael;Fischer Christian;Haidle Andrew M.;Kattar Solomon D.;Northrup Alan B.;Schell Adam J.;Smith Graham F.;Taoka Brandon M.;Bienstock Corey;Di Francesco Maria Emilia;Donofrio Anthony;Peterson Scott;Spencer Kerrie B.;Jewell James Patrick;Ali Amjad;Bennett David Jonathan;Dang Qun;Wai John
分类号 C07D401/14 主分类号 C07D401/14
代理机构 代理人
主权项 1. A compound having formula I or a pharmaceutically acceptable salt thereof, wherein R1 is C1-4alkyl, C1-4fluoroalkyl, C3-6cycloalkyl or C1-4alkoxy; R2 is H or halogen; R3 is H, halogen, NRbRc, C1-4alkyl, C1-4haloalkyl, C3-6cycloalkyl or C1-4hydroxyalkyl; R4 is H or halogen; one of X1 and X2 is N, and the other is C—F, C-Q or C—Y—Z; Q is selected from (a) C1-4alkyl optionally substituted with 1 to 2 groups independently selected from ORa and CO2Ra, and (b) NH—C1-4alkyl optionally substituted with CO2Ra; Y is selected from the group consisting of (a) a bond, (b)—O(CH2)0-1—, (c) —NH(CH2)0-1, (d) —C(R5)(R6), and (e) —C(O)—; R5 is H, OH, C1-4alkoxy or halogen; R6 is H, C1-4alkyl, C1-4haloalkyl, C3-6cycloalkyl or C1-4hydroxyalkyl; Z is (a) aryl or a carbocycle each optionally substituted with 1-5 groups independently selected from C1-4alkyl, ORa, CO2Ra, and CONRbRc, or (b) heteroaryl or a 4- to 10-membered mono- or bicyclic heterocycle each optionally substituted with 1 or 2 groups independently selected from oxo, ORa, CO2Ra, CONRbRc, CORd, NRbRc, NHC(O)ORa, NHCORd, NHCONRbRc, and cyclohexyl optionally substituted with CO2Ra; Ra is selected from the group consisting of: (i) H;(ii) C1-8 alkyl;(iii) a group of the formula -M-RCH, wherein M is a bond or —(CH2)1-2—;RCH is (a) aryl or carbocycle optionally substituted with 1-3 groups independently selected from halo, C1-4alkyl, or C1-4alkoxy; or (b) a 5- to 6-membered monocyclic heterocycle containing 1 or 2 heteroatoms independently selected from the group consisting of N and O, wherein said heterocycle of RCH is optionally substituted with 1 or 2 groups independently selected from the group consisting of oxo and C1-3 alkyl;(iv) a group of the formula —(CH2)1-2—Re or —(CH2)2—O—(CH2)2—Re wherein Re is CO2Re1, C(O)N(Re2)2, or —(CO)Re1; Re1 is C1-4alkyl; andRe2 is H or C1-4alkyl;(v) a group of the formula —(CH2)2—Rf, Rf is OH, —OC1-4alkyl, NH2, —N(H)(C1-4alkyl) or N(C1-4alkyl)2;(vi) a group of the formula wherein Rg is H or C1-4alkyl; andRh is C1-4alkyl, C3-6cycloalkyl, or phenyl; and,(vii) a group of the formulawherein Rg and Rh are as set forth above; Rb and Rc are each independently selected from H and C1-4alkyl; or Rb, Re and the nitrogen atom to which they are attached together form a 4- to 6-membered ring optionally having an additional heteroatom selected from N—Ra, O and S, wherein said ring is optionally substituted with a group selected from CO2Ra and oxo; Rd is (a) C1-4alkyl optionally substituted with NRbRc, O-aryl, aryl, heteroaryl, or V—W, (b) aryl, (c) heteroaryl, (d) V—W, or (e) a group selected from 1-isoindolinone, 2-indolinone, fluorenyl (optionally substituted with oxo), tetrahydrocarbazolyl, and dibenzo[b,d]furanyl; wherein V and W are each independently selected from aryl and heteroaryl, and aryl and heteroaryl in (a) through (d) are each optionally substituted with 1-3 groups independently selected from (i) C1-4alkyl, (ii) C1-4haloalkyl, (iii) CN, (iv) halogen, (v) ORa, (vi) phenoxy, (vii) CH2-aryl, (viii) CH2-heteroaryl, (ix) NRbRc, (x) CONRbRc, (xi) NHCOC1-4alkyl, and (xii) SO2C1-4alkyl.
地址 Lachine CA